Recent price hikes for life-saving drugs prompt this discussion on prescription pricing. Scott says it’s like Robin Hood in reverse — the real payers of prescriptions are propping up a dysfunctional system. Scott and Anne Marie say the lack of transparency masks the dollars that are being exchanged under the counter. And until employers know where their money is going, it will only continue.
Hood Robin by Scott McGohan (White Paper)
12 Pharma statistics that you should know (Article)
Why Americans spend so much on pharmaceuticals (Article)
Scott and Anne Marie welcome guest Antonio Ciaccia of the Ohio Pharmacists Association to talk about high prescription drug prices. Ciaccia says a “dysfunctional system” allows a lack of transparency, and that makes it possible for middlemen within the pharmacy supply chain to negotiate high prices in secrecy.
Scott and Anne Marie welcome back Antonio Ciaccia of the Ohio Pharmacy Association to dissect Issue 2, the Ohio Drug Price Relief Act that was subsequently defeated in Ohio in November 2017. Learn why pharmacists believed the issue, which purported to lower drug prices, would have unintended consequences for consumers.
A month before the November 2017 election, Ohioans were still unclear on Issue 2, the Ohio Drug Price Relief Act. On the surface, it sounds like a good thing for Ohio consumers. Scott and Anne Marie are joined by MB colleagues Michael Orr and Adam Griffith to examine Issue 2 may, in fact, have the opposite effect.
Scott and Anne Marie welcome Jay Meyer to share his story of overcoming opioid addiction. Meyer, a former pharmacist, tells a chilling story of how easy it is to slip into addiction, and how difficult it is to emerge. Now a personal development coach, Meyer shared his insights from his personal journey.